Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination
暂无分享,去创建一个
M. Hassan | A. Yassin | Alaa Elmazny | M. Hussein | Rehab Magdy | H. Abdel-Hamid | E. Elsebaie | W. Fathy | Shaimaa H. Soliman | S. H. Ali | Aliaa Abdel Fattah | Radwa M. Elsayed | Mohamed Abdelbadie | Noha A. Mahfouz | Ahmed Yassin | R. Magdy | Eman H. Elsebaie | E. H. Elsebaie | Ali M. Abdel Fattah
[1] G. Lippi,et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review , 2022, eClinicalMedicine.
[2] E. Kvašňák,et al. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications , 2022, Frontiers in Public Health.
[3] N. Kootstra,et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study , 2022, Vaccine.
[4] K. Khunti,et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study , 2022, BMJ.
[5] A. S. Abdel-Moneim,et al. Neuropsychiatric symptoms in post COVID-19 long haulers. , 2022, Acta neuropsychiatrica.
[6] A. Brunoni,et al. Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation , 2022, Psychological Medicine.
[7] A. Iwasaki,et al. Unexplained post-acute infection syndromes , 2022, Nature Medicine.
[8] N. Wenger,et al. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort , 2022, Journal of General Internal Medicine.
[9] D. Spandidos,et al. Long COVID and neuropsychiatric manifestations (Review) , 2022, Experimental and therapeutic medicine.
[10] Usha Govindarajulu,et al. Association of Vaccination with the Persistence of Post-COVID Symptoms , 2022, Journal of General Internal Medicine.
[11] A. Charlett,et al. Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection , 2022, The New England journal of medicine.
[12] Elisabeth Mahase. Covid-19: Vaccinated people are less likely to get long covid, review finds , 2022, BMJ.
[13] D. Yahav,et al. ESCMID rapid guidelines for assessment and management of long COVID , 2022, Clinical Microbiology and Infection.
[14] Maria Papadopoulou,et al. Neurological manifestations of long-COVID syndrome: a narrative review , 2022, Therapeutic advances in chronic disease.
[15] Janet Diaz,et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.
[16] J. García-Moncó,et al. Epidemiology, pathophysiology, and classification of the neurological symptoms of post-COVID-19 syndrome , 2021, Neurology Perspectives.
[17] F. Bai,et al. Female gender is associated with long COVID syndrome: a prospective cohort study , 2021, Clinical Microbiology and Infection.
[18] T. Spector,et al. Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[19] G. Giovannoni,et al. Long COVID or post COVID-19 syndrome , 2021, Multiple Sclerosis and Related Disorders.
[20] Zhancheng Gao,et al. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis , 2021, Frontiers in Medicine.
[21] A. Dagens,et al. Characterising long COVID: a living systematic review , 2021, BMJ Global Health.
[22] D. Sanchez-Ramirez,et al. Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis , 2021, Biomedicines.
[23] Michelle A. Williams,et al. Confronting Our Next National Health Disaster - Long-Haul Covid. , 2021, The New England journal of medicine.
[24] H. Ashrafian,et al. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis , 2021, EClinicalMedicine.
[25] C. Robertson,et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study , 2021, BMJ.
[26] P. Boscolo-Rizzo,et al. Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study , 2021, The Journal of Laryngology & Otology.
[27] Z. Ormianer,et al. Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients , 2021, American Journal of Otolaryngology.
[28] Donald S. Grant,et al. Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Paul J. Harrison,et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records , 2021, The Lancet Psychiatry.
[30] W. Lim,et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol , 2021, The Lancet Regional Health - Europe.
[31] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[32] C. Pepine,et al. Sex and gender differences in COVID-19: More to be learned! , 2021, American Heart Journal Plus: Cardiology Research and Practice.
[33] Y. Benjamini,et al. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients , 2021, Clinical Microbiology and Infection.
[34] C. Wolf,et al. Sequelae in Adults at 6 Months After COVID-19 Infection , 2021, JAMA network open.
[35] S. Villapol,et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis , 2021, Scientific Reports.
[36] L. Klimek,et al. COVID‐19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste , 2021, The Laryngoscope.
[37] Guohui Fan,et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.
[38] P. Wostyn. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? , 2021, Medical Hypotheses.
[39] Paul J. Harrison,et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA , 2020, The Lancet Psychiatry.
[40] C. Hopkins,et al. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. , 2020, Rhinology.
[41] G. Malavige,et al. Dengue and post-infection fatigue: findings from a prospective cohort-the Colombo Dengue Study. , 2020, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[42] P. Portincasa,et al. Gaining Back What Is Lost: Recovering the Sense of Smell in Mild to Moderate Patients After COVID-19 , 2020, Chemical senses.
[43] F. Callard,et al. How and why patients made Long Covid , 2020, Social Science & Medicine.
[44] Murugappan Ramanathan,et al. Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication , 2020, European Respiratory Journal.
[45] N. Maskell,et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. , 2020, medRxiv.
[46] Junaith S Mohamed,et al. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies , 2020, Journal of applied physiology.
[47] M. Brenner,et al. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[48] T. R. Jordan,et al. COVID-19 pandemic and psychological fatigue in Turkey , 2020, The International journal of social psychiatry.
[49] Angelo Carfì,et al. Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.
[50] C. Torp‐Pedersen,et al. Association between male sex and outcomes of Coronavirus Disease 2019 (Covid‐19) – a Danish nationwide, register-based study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] D. Lombardi,et al. Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[52] M. Benros,et al. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence , 2020, Brain, Behavior, and Immunity.
[53] Taiwen Li,et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa , 2020, International Journal of Oral Science.
[54] A. Beekman,et al. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls , 2019, International journal of geriatric psychiatry.
[55] A. Terkawi,et al. Development and validation of Arabic version of the douleur neuropathique 4 questionnaire , 2017, Saudi journal of anaesthesia.
[56] E. Clayton. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. , 2015, JAMA.
[57] Michael B First,et al. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. , 2013, The Journal of nervous and mental disease.
[58] J. Olesen. ICHD-3 beta is published. Use it immediately , 2013, Cephalalgia : an international journal of headache.
[59] R. Ohrbach,et al. The International Classification of Headache Disorders, 3rd edition (beta version) , 2013, Cephalalgia : an international journal of headache.
[60] M. Hotopf,et al. Predictors of fatigue following the onset of infectious mononucleosis , 2003, Psychological Medicine.
[61] D. Crawford,et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis , 2001, The Lancet.
[62] T. Rea,et al. Acute infectious mononucleosis: characteristics of patients who report failure to recover. , 2000, The American journal of medicine.
[63] W. Tunnicliffe,et al. Post-infection fatigue syndrome following Q fever. , 1998, QJM : monthly journal of the Association of Physicians.
[64] S. Sheather,et al. Clinical applications of visual analogue scales: a critical review , 1988, Psychological Medicine.